Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Crescent Biopharma - 19 Year Stock Price History | CBIO

Historical daily share price chart and data for Crescent Biopharma since 2006 adjusted for splits and dividends. The latest closing stock price for Crescent Biopharma as of June 27, 2025 is 15.90.
  • The all-time high Crescent Biopharma stock closing price was 152189.00 on December 04, 2009.
  • The Crescent Biopharma 52-week high stock price is 63.00, which is 296.2% above the current share price.
  • The Crescent Biopharma 52-week low stock price is 11.06, which is 30.4% below the current share price.
  • The average Crescent Biopharma stock price for the last 52 weeks is 24.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Crescent Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 23.9575 26.0000 36.0000 13.2700 15.9000 -36.40%
2024 110.5595 272.0000 349.0000 14.0000 25.0000 -89.41%
2023 176.3280 291.0000 405.0000 113.0000 236.0000 -22.11%
2022 102.6135 158.0000 303.0000 54.0000 303.0000 110.42%
2021 250.1905 373.0000 422.0000 144.0000 144.0000 -61.70%
2020 349.5099 518.0000 541.0000 183.0000 376.0000 -28.92%
2019 876.9127 1002.0000 1344.0000 280.0000 529.0000 -44.14%
2018 1625.5179 1708.0000 2535.0000 847.0000 947.0000 -43.60%
2017 985.5100 627.0000 1722.0000 389.0000 1679.0000 175.25%
2016 649.4008 587.0000 897.0000 381.0000 610.0000 6.64%
2015 746.4365 744.0000 896.0000 498.0000 572.0000 -20.56%
2014 931.0956 577.6900 1700.0000 566.5830 720.0000 24.93%
2013 674.8641 648.5140 826.2670 534.6470 576.3030 -5.25%
2012 685.2029 780.4410 1041.5100 554.0880 608.2460 -21.36%
2011 2724.1914 3723.0700 4157.7300 692.9520 773.4960 -78.98%
2010 3022.2229 2845.4200 3763.3400 2528.8000 3680.0200 26.79%
2009 58319.7502 23359.4000 152189.0000 2902.3600 2902.3600 -87.26%
2008 43055.5249 52671.0000 63998.6000 10432.0000 22783.6000 -56.90%
2007 58919.6737 58879.1000 69055.1000 51198.7000 52863.2000 -8.73%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.010B $0.000B
Crescent Biopharma is a biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors. Crescent Biopharma, formerly known as GlycoMimetics Inc., is based in ROCKVILLE, Md.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.719B 32.53
Zoetis (ZTS) United States $69.528B 25.94
Takeda Pharmaceutical (TAK) Japan $48.047B 9.56
Daiichi Sankyo, - (DSNKY) Japan $43.343B 22.21
BeOne Medicines - (ONC) Cayman Islands $26.436B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.802B 0.00
Merck (MKKGY) Germany $17.015B 12.47
Summit Therapeutics (SMMT) United States $15.299B 0.00
Shionogi (SGIOY) Japan $14.887B 14.91
United Therapeutics (UTHR) United States $12.823B 11.34
Neurocrine Biosciences (NBIX) United States $12.412B 42.52
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.765B 63.12
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Ionis Pharmaceuticals (IONS) United States $6.335B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.092B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.195B 0.00
Hypermarcas (HYPMY) Brazil $3.072B 20.21
Crinetics Pharmaceuticals (CRNX) United States $2.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.657B 9.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.085B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.959B 0.00
ARS Pharmaceuticals (SPRY) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.754B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.469B 0.00
Guardian Pharmacy Services (GRDN) United States $1.353B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.167B 23.35
Harrow (HROW) United States $1.133B 0.00
Dyne Therapeutics (DYN) United States $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.015B 0.00
Verve Therapeutics (VERV) United States $1.007B 0.00
Collegium Pharmaceutical (COLL) United States $0.962B 5.19
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.890B 0.00
Ardelyx (ARDX) United States $0.883B 0.00
Elite Pharmaceuticals (ELTP) United States $0.760B 0.00
Xeris Biopharma Holdings (XERS) United States $0.735B 0.00
Cronos Group (CRON) Canada $0.733B 0.00
USANA Health Sciences (USNA) United States $0.580B 12.60
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.561B 0.00
Bioventus (BVS) United States $0.556B 14.10
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
AleAnna (ANNA) United States $0.481B 0.00
Organogenesis (ORGO) United States $0.466B 0.00
Siga Technologies (SIGA) United States $0.462B 9.64
Tourmaline Bio (TRML) United States $0.425B 0.00
Oruka Therapeutics (ORKA) United States $0.415B 0.00
Savara (SVRA) United States $0.382B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.348B 9.41
Heron Therapeutics (HRTX) United States $0.326B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.320B 0.00
Altimmune (ALT) United States $0.284B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 24.58
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
Liminatus Pharma (LIMN) United States $0.247B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.213B 0.00
MediWound (MDWD) Israel $0.208B 0.00
OmniAb (OABI) United States $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.197B 0.00
ProKidney (PROK) United States $0.196B 0.00
Larimar Therapeutics (LRMR) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Galectin Therapeutics (GALT) United States $0.147B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Korro Bio (KRRO) United States $0.113B 0.00
VAXART, INC (VXRT) United States $0.113B 0.00
Protara Therapeutics (TARA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.107B 17.64
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Unicycive Therapeutics (UNCY) United States $0.086B 0.00
Cassava Sciences (SAVA) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Achieve Life Sciences (ACHV) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.039B 28.89
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.17
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.16
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00